FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Science That Changes Lives

From breakthroughs in the lab to real-world progress—accelerating research that delivers results for families today.

Thank you

Thank you for signing up to receive MDA’s professional medical education newsletters. For more information please visit MDA’s Professional Medical Education Page.

Find MDA
in your Community